title: Effectiveness of photodynamic therapy with topical 5-aminolevulinic acid and intense pulsed light in Chinese acne vulgaris patients.
abstract: BACKGROUND
  The success rates of conventional treatments to acne vulgaris are limited because of intolerance and resistance. Photodynamic therapy with topical 5-aminolevulinic acid (ALA) and red light has been introduced. However, the side effects especially pigmentation are common.
  
  
  OBJECTIVE
  To study the efficacy and safety of ALA-photodynamic therapy (PDT) with 420-950 nm intense pulsed light (IPL) in Chinese patients with acne vulgaris.
  
  
  METHODS
  Forty-one patients with moderate to severe facial acne were randomly assigned to ALA-IPL-PDT group and IPL group. Ten percent topical ALA was applied to patients in the ALA-IPL-PDT group, while placebos were applied to patients in the IPL group. After 1 h occlusion, all patients were illuminated with 420-950 nm IPL. The patients in both groups had four treatment sessions with 1-week intervals. One week after each treatment and 4, 8, and 12 weeks after four sessions, acne lesion counts and adverse events were observed.
  
  
  RESULTS
  Twelve weeks after treatments, mean reductions of global lesion counts of ALA-IPL-PDT group and IPL group were 75.2% and 51.0%, respectively. Mean reductions of inflammatory and non-inflammatory lesion counts in ALA-IPL-PDT group were (83.6 ± 4.1)% and (57.5 ± 6.8)%, respectively. No severe adverse events were observed.
  
  
  CONCLUSIONS
  ALA-IPL-PDT is an effective treatment for moderate to severe acne vulgaris, and side effects are mild and reversible.
authors: Dermatology Department, Shanghai First People's Hospital, Shanghai, China. meixingyu24@hotmail.com
authors: Xingyu
authors: X
authors: Mei
authors: Weimin
authors: W
authors: Shi
authors: Yinglan
authors: Y
authors: Piao
mesh_terms: D000152:Acne Vulgaris / Q000628:therapy*; D000328:Adult; D000622:Aminolevulinic Acid / Q000009:adverse effects / Q000627:therapeutic use*; D044466:Asian People; D002681:China; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D062325:Intense Pulsed Light Therapy / Q000009:adverse effects; D008297:Male; D010778:Photochemotherapy / Q000009:adverse effects; D017319:Photosensitizing Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D017319:Photosensitizing Agents; D000622:Aminolevulinic Acid